Discover the future of lateral flow, the market factors and technologies driving change.
BBI Solutions has been shaping the future of lateral flow technology for over 30 years, combining an innovative and flexible approach with unparalleled knowledge and a commitment to high quality standards. Meet our team today.
At AACC, 1st-3rd August in San Diego, USA, BBI Solutions held a breakfast seminar on MorffiTM signal enhancement: an evolution in assay development, and they presented their poster: Increasing the limit of detection and performance of rapid immunological tests. At the end of the seminar and poster session, many questions were asked about the Morffi technology. Here are our answers.
Presenting at a recent ‘Lateral Flow Test Development Workshop’ hosted by BBI Solutions, Merck and Kinematic Automation, Chris Walkinshaw showcased a variety of ‘Real Life Lateral Flow Case Studies.’ We caught up with Chris for him to share some insight into his experience, development advice and predictions for the future.
Taking place on the 28th July every year, World Hepatitis Day strives to raise awareness of viral hepatitis one of the leading causes of death globally. An estimated 325 million people were living with chronic hepatitis infections (HBV or HCV) worldwide in 2015 and this global epidemic accounted for 1.34 million deaths that same year. Currently, 90% of people living with hepatitis B and 80% living with hepatitis C are not aware of their status.
Last month we brought to you the first in a series of webinars "The Ultimate Guide to Lateral Flow." The event was a great success with attendees from all over the world logging on to hear about lateral flow and considerations when embarking on a development project. Darren Rowles, BBI's Product Manager for Lateral Flow and Gold Nanoparticles, hosted the session and was joined by Karen Whiting the Global Head of New Product Development whose team were responsible for developing Morffi: Signal Enhancement technology. A live Q&A session unearthed some interesting questions, so we thought we’d summarise them for you.
Jonathan is the newly appointed Business Development Manager for the lateral flow services team for BBI Solutions
International Standards and International Reference Preparations are available for most tumour markers measured by immunoassay, which improve the accuracy and comparability of assay results. If the benefits of standardisation are clear, should we not be striving to provide standards for all tumour markers?